Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation

被引：0

作者：

Buldini, Barbara ^{[1
]}

Merli, Pietro ^{[2
]}

Varotto, Elena ^{[1
,3
]}

Masetti, Riccardo ^{[4
]}

Gabelli, Maria ^{[1
]}

Zecca, Marco ^{[5
]}

Fagioli, Franca ^{[6
]}

Scarparo, Pamela ^{[1
]}

Algeri, Mattia ^{[2
]}

Biffi, Alessandra ^{[7
]}

Pigazzi, Martina ^{[8
]}

Pagliara, Daria ^{[2
]}

Locatelli, Franco ^{[9
,10
]}

机构：

[1] Univ Padua, Pediat Hematol Oncol & Stem Cell Transplant Div, Maternal & Child Hlth Dept, Padua, Italy

[2] Bambino Gesu Children Hosp, Dept Haematol Oncol & Cell & Gene Therapy, Rome, Italy

[3] Univ Padua, Padua, Italy

[4] Dept P, Pediat Oncol & Hematol Unit lalla Seragnoli, Bologna, Italy

[5] Fdn IRCCS Policlin San Matteo, Pediat Hematol Oncol, Pavia, Italy

[6] Univ Turin, Regina Margherita Childrens Hosp, Pediat Onco Hematol Stem Cell Transplantat & Cell, Turin, Italy

[7] Padua Univ Hosp, Pediat Hematol Oncol & Stem Cell Transplant Div, Padua, Italy

[8] Univ Padua, Dept Womens & Childrens Hlth, Oncohematol Lab & Clin, Padua, Italy

[9] Univ Cattolica Sacro Cuore, Dept Pediat Hematol & Oncol, IRCCS Osped Pediatr Bambino Gesu, Rome, Italy

[10] Univ Cattolica Sacro Cuore, Bambino Gesu Childrens Hosp, Rome, Italy

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-189080

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
Rodriguez-Arboli, Eduardo
Orvain, Corentin
Othus, Megan
Walter, Roland B.
BONE MARROW TRANSPLANTATION, 2022, 57 (11) : 1732 - 1734
[32] ROLE OF MEASURABLE RESIDUAL DISEA SE QUANTIFIED BY MULTIPARAMETRIC FLOW CYTOMETRY BEFORE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGHRISK PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Kanoun, Rimmel Yosra
Mekni, Sabrine
Ben Abdeljelil, Nour
Ouerghi, Rihab
Ben Yaiche, Insaf
Turki, Ines
Ladeb, Saloua
Torjmane, Lamia
Belloumi, Dorra
Safra, Ines
Ben Othman, Tarek
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 473 - 474
[33] Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission
Konova, Zoya V.
Parovichnikova, Elena N.
Galtseva, Irina V.
Kapranov, Nikolay M.
Davydova, Julia O.
Drokov, Mikhail Yu.
Nareyko, Maria V.
Popova, Natalia N.
Dmitrova, Anna A.
Maslikova, Ulyana V.
Starikova, Olga S.
Usikova, Ekaterina I.
Mikhaltsova, Ekaterina D.
Koroleva, Olga M.
Vasilyeva, Vera A.
Lobanova, Tatiana I.
Kuzmina, Larisa A.
Savchenko, Valeriy G.
BLOOD, 2019, 134
[34] Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia
Norkin, Maxim
Katragadda, Lakshmikanth
Zou, Fei
Xiong, Sican
Chang, Myron
Dai, Yunfeng
Hsu, Jack W.
Moreb, Jan S.
Leather, Helen
Murthy, Hemant S.
Farhadfar, Nosha
Li, Ying
Hromas, Robert
Brown, Randy A.
Cogle, Christopher R.
Wingard, John R.
BLOOD CANCER JOURNAL, 2017, 7
[35] Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia
Maxim Norkin
Lakshmikanth Katragadda
Fei Zou
Sican Xiong
Myron Chang
Yunfeng Dai
Jack W. Hsu
Jan S. Moreb
Helen Leather
Hemant S. Murthy
Nosha Farhadfar
Ying Li
Robert Hromas
Randy A. Brown
Christopher R. Cogle
John R. Wingard
Blood Cancer Journal, 7
[36] Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Walter, Roland B.
Gooley, Ted A.
Wood, Brent L.
Milano, Filippo
Fang, Min
Sorror, Mohamed L.
Estey, Elihu H.
Salter, Alexander I.
Lansverk, Emily
Chien, Jason W.
Gopal, Ajay K.
Appelbaum, Frederick R.
Pagel, John M.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1190 - 1197
[37] The Effect of Measurable Residual Disease at the Time of Allogeneic Hematopoietic Cell Transplantation on Outcomes in Patients with Acute Myeloid Leukemia: A Meta-Analysis
Buckley, Sarah A.
Wood, Brent L.
Othus, Megan
Hourigan, Christopher S.
Ustun, Celalettin
Linden, Michael A.
Defor, Todd E.
Malagola, Michele
Kanakry, Christopher G.
Gruhn, Bernd
Devine, Beth
Walter, Roland B.
BLOOD, 2016, 128 (22)
[38] Single-Cell Multiomics Data-Driven Measurable Residual Disease (MRD) Assessment Using Multidimensional Flow Cytometry (MFC) in Acute Myeloid Leukemia (AML)
Gonzalez, Carmen
Simoes, Catia
Burgos, Leire
Martinez-Cuadron, David
Sarvide, Sarai
Alignani, Diego
Lopez, Aitziber
Gui, Yujuan
Komic, Hana
Schmachtel, Tessa
Botella, Carmen
Boyero, Raimundo Garcia
Santaolla, Esther Perez
Gil, Cristina
Algarra, Jesus Lorenzo
Lloris, Maria Jose Sayas
Ibanez, Francisco
Torres, Laura
Cano-Ferri, Isabel
Acuna-Cruz, Evelyn
Arce, Olga
Thoren, Fredrik B.
Rieger, Michael A.
San-Miguel, Jesus F.
Prosper, Felipe
Montesinos, Pau
Paiva, Bruno
BLOOD, 2024, 144 : 4328 - 4329
[39] Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
S Kayser
A Benner
C Thiede
U Martens
J Huber
P Stadtherr
J W G Janssen
C Röllig
M J Uppenkamp
T Bochtler
U Hegenbart
G Ehninger
A D Ho
P Dreger
A Krämer
Blood Cancer Journal, 2016, 6 : e449 - e449
[40] Pre-Transplant Minimal Residual Disease Determined By Multiparameter Flow Cytometry Is Better Than RQ-PCR to Predict the Outcomes of Ph plus ALL Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Zhao, Xiaosu
Liu, Yanrong
Qin, Yazhen
Wang, Yu
Zhang, Xiaohui
Xu, Lanping
Huang, Xiaojun
Chang, Yingjun
BLOOD, 2017, 130

← 1 2 3 4 5 →